- Home
- SFST vs ABEO Comparison
SFST vs ABEO Comparison
Compare SFST & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- ABEO
- Stock Information
- Founded
- SFST 1999
- ABEO N/A
- Country
- SFST United States
- ABEO United States
- Employees
- SFST N/A
- ABEO N/A
- Industry
- SFST Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- ABEO Health Care
- Exchange
- SFST Nasdaq
- ABEO Nasdaq
- Market Cap
- SFST 344.3M
- ABEO 247.8M
- IPO Year
- SFST 1999
- ABEO 1980
- Fundamental
- Price
- SFST $40.65
- ABEO $5.70
- Analyst Decision
- SFST Buy
- ABEO Strong Buy
- Analyst Count
- SFST 1
- ABEO 3
- Target Price
- SFST $44.00
- ABEO $18.00
- AVG Volume (30 Days)
- SFST 21.9K
- ABEO 229.2K
- Earning Date
- SFST 01-16-2025
- ABEO 11-14-2024
- Dividend Yield
- SFST N/A
- ABEO N/A
- EPS Growth
- SFST N/A
- ABEO N/A
- EPS
- SFST 1.73
- ABEO N/A
- Revenue
- SFST $90,166,000.00
- ABEO N/A
- Revenue This Year
- SFST N/A
- ABEO N/A
- Revenue Next Year
- SFST $13.55
- ABEO $18,714.71
- P/E Ratio
- SFST $23.50
- ABEO N/A
- Revenue Growth
- SFST 3.18
- ABEO 147.52
- 52 Week Low
- SFST $24.98
- ABEO $3.05
- 52 Week High
- SFST $45.91
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- SFST 43.15
- ABEO 34.30
- Support Level
- SFST $39.47
- ABEO $5.45
- Resistance Level
- SFST $42.99
- ABEO $6.04
- Average True Range (ATR)
- SFST 1.30
- ABEO 0.19
- MACD
- SFST -0.58
- ABEO -0.04
- Stochastic Oscillator
- SFST 26.34
- ABEO 19.47
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.